Should We Continue or Discontinue Inflammatory Bowel Disease Medication in Patients With Coronavirus Disease 2019?
Gastroenterology
.
2022 Jul;163(1):338-339.
doi: 10.1053/j.gastro.2022.03.008.
Epub 2022 Mar 12.
Authors
Yuki Hayashi
1
,
Hiroshi Nakase
1
,
Tadakazu Hisamatsu
2
;
J-COSMOS group
Affiliations
1
Department of Gastroenterology and Hepatology, Sapporo Medical University of Medicine, Sapporo, Japan.
2
Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan.
PMID:
35288110
PMCID:
PMC8916839
DOI:
10.1053/j.gastro.2022.03.008
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Chronic Disease
Humans
Inflammatory Bowel Diseases* / drug therapy